BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Advarra - ECPv6.15.12.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.advarra.com
X-WR-CALDESC:Events for Advarra
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250623T130000
DTEND;TZID=America/New_York:20250623T140000
DTSTAMP:20260412T190821
CREATED:20250603T162926Z
LAST-MODIFIED:20250603T165739Z
UID:64566-1750683600-1750687200@www.advarra.com
SUMMARY:From Ethics to Evidence: Applying Real-World Data in Oncology Trials
DESCRIPTION:From Ethics to Evidence: Applying Real-World Data in Oncology Trials\n\n\n\n\n\n\n\n\nAs part of Oncology Research Pulse\, our new thought leadership initiative designed to foster collaboration that advances oncology research\, we’re partnering with Fierce Pharma to explore how to ethically and effectively incorporate RWD into oncology clinical research. \n\n\n\n\n\nReal-world data (RWD) is a powerful asset for pharmaceutical sponsors looking to enhance oncology trial design\, support regulatory submissions\, and demonstrate real-world value. From generating external control arms to identifying patient cohorts and uncovering long-term safety signals\, RWD offers strategic advantages across the development lifecycle. But as the stakes grow\, so does the ethical responsibility to use RWD with transparency\, fairness\, and patient-centered rigor.This webinar will explore how to ethically and effectively incorporate RWD into oncology clinical research. Industry leaders and experts will share insights on navigating consent\, bias\, and data provenance—while aligning with regulatory expectations and building confidence in research practices. \n\n\n\n\n\nKey Takeaways\n\n\n\n\nHow RWD can be used to improve oncology clinical trial design and operations\n\n\n\nEthical considerations around patient privacy\, informed consent\, and data provenance—and strategies to align scientific\, ethical\, and reputational goals in trial design\n\n\n\nFDA\, EMA\, and global guidance on the responsible use of RWD\n\n\n\nDesigned for R&D\, clinical strategy\, and regulatory leaders\, this session offers a practical framework for building responsible\, high-impact RWD programs in oncology research.\n\n\n\n\n\n\nFeatured Speakers\n\n\n\n\n\nSean CunninghamRegional Director\, Americas – Study Site EngagementTakeda Pharmaceuticals \n\n\n\n\n\nMeredith HightowerDirector\, Strategic Site Partnerships\, Clinical Field Excellence\, CSMAbbVie \n\n\n\nSara MoelleringDirector of Clinical Research OperationsUniversity of Chicago \n\n\n\nSara RaboinPhDDirector of Operations Yale Cancer Center
URL:https://www.advarra.com/event/from-ethics-to-evidence-applying-real-world-data-in-oncology-trials/
CATEGORIES:Third-Party Webinars,Webinar
ATTACH;FMTTYPE=image/png:https://www.advarra.com/wp-content/uploads/Fierce-Pharma-Logo.png
END:VEVENT
END:VCALENDAR